The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

NASACORT 55 micrograms/dose nasal spray, suspension

Lexon (UK) LtdPPA1097/032/001

Main Information

Trade NameNASACORT 55 micrograms/dose nasal spray, suspension
Active SubstancesTriamcinolone acetonide
Dosage FormNasal spray, suspension
Licence HolderLexon (UK) Ltd
Licence NumberPPA1097/032/001

Group Information

ATC CodeR01AD11 triamcinolone


License statusAuthorised
Licence Issued30/08/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back